• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯氧苄胺(双苄胺)对男性性功能的影响。

Effect of phenoxybenzamine (dibenzyline) on sexual function in man.

作者信息

Kedia K R, Persky L

出版信息

Urology. 1981 Dec;18(6):620-1. doi: 10.1016/0090-4295(81)90474-x.

DOI:10.1016/0090-4295(81)90474-x
PMID:6118973
Abstract

Phenoxybenzamine (Dibenzyline) has been extremely effective in treating patients with detrusor dyssynergia. Its minimal side effects include: mouth dryness, nasal congestion, drowsiness and fatigue, nausea and vomiting, palpitations, ejaculatory failure, and retrograde ejaculation. Nineteen men treated with phenoxybenzamine for detrusor dyssynergia reported ejaculatory failure during treatment; normal ejaculation returned after treatment was discontinued. Postmasturbation urine and semen samples were analyzed for sperm and fructose. The results of the study suggest that ejaculatory failure was due to the lack of seminal emission into the posterior urethra, rather than retrograde ejaculation. Some implications of this study are also discussed.

摘要

酚苄明(双苄胺)在治疗逼尿肌协同失调患者方面极为有效。其轻微副作用包括:口干、鼻塞、嗜睡和疲劳、恶心和呕吐、心悸、射精失败以及逆行射精。19名接受酚苄明治疗逼尿肌协同失调的男性在治疗期间报告出现射精失败;治疗停止后射精恢复正常。对自慰后的尿液和精液样本进行了精子和果糖分析。研究结果表明,射精失败是由于缺乏精液排入后尿道,而非逆行射精。本文还讨论了该研究的一些意义。

相似文献

1
Effect of phenoxybenzamine (dibenzyline) on sexual function in man.苯氧苄胺(双苄胺)对男性性功能的影响。
Urology. 1981 Dec;18(6):620-1. doi: 10.1016/0090-4295(81)90474-x.
2
Long-term alpha-adrenergic-blocking therapy in detrusor-urethra dyssynergia.用于治疗逼尿肌-尿道协同失调的长期α-肾上腺素能阻滞剂疗法。
Eur Urol. 1983;9(3):167-9. doi: 10.1159/000474074.
3
Alpha-adrenolytic treatment of the congenital neuropathic bladder.先天性神经性膀胱的α-肾上腺素能阻断治疗
Urol Int. 1975;30(1):33. doi: 10.1159/000279957.
4
Effect of an alpha-blocking agent (phenoxybenzamine) in the management of premature ejaculation.α受体阻滞剂(酚苄明)在早泄治疗中的作用。
Acta Eur Fertil. 1986 Jan-Feb;17(1):43-5.
5
Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission.α-1肾上腺素能受体拮抗剂引起的射精障碍并非逆行射精,而是无精液射出。
Int J Urol. 2006 Oct;13(10):1311-6. doi: 10.1111/j.1442-2042.2006.01535.x.
6
Inhibition of Seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers.在正常志愿者中,抑制射精是一种新型高选择性α1A阻滞剂所致不射精的主要原因。
J Sex Med. 2008 Sep;5(9):2185-90. doi: 10.1111/j.1743-6109.2008.00779.x. Epub 2007 Apr 9.
7
Analysis of human ejaculation using color Doppler ultrasonography: a comparison between antegrade and retrograde ejaculation.应用彩色多普勒超声对人类射精进行分析:顺行射精与逆行射精的比较
Urology. 2005 Feb;65(2):365-8. doi: 10.1016/j.urology.2004.09.016.
8
A modern rationale for the use of phenoxybenzamine in urinary tract disorders and other conditions.使用苯氧苄胺治疗泌尿系统疾病及其他病症的现代理论依据。
Clin Ther. 2002 Jun;24(6):851-61; discussion 837. doi: 10.1016/s0149-2918(02)80003-0.
9
Silodosin causes impaired ejaculation and enlargement of seminal vesicles in sexually active men treated for lower urinary tract symptoms suggestive of benign prostatic hyperplasia.在接受治疗以缓解提示良性前列腺增生的下尿路症状的性活跃男性中,西洛多辛会导致射精功能障碍和精囊增大。
Urology. 2015 May;85(5):1085-1089. doi: 10.1016/j.urology.2015.01.011. Epub 2015 Mar 3.
10
The place of alpha-blocking drugs in the treatment of children with neuropathic bladders.
Urol Int. 1977;32(2-3):224-31. doi: 10.1159/000280135.

引用本文的文献

1
The future of male contraception: a fertile ground.男性避孕的未来:一片沃土。
Transl Androl Urol. 2018 May;7(Suppl 2):S220-S235. doi: 10.21037/tau.2018.03.23.
2
As the world grows: contraception in the 21st century.随着世界的发展:21世纪的避孕
J Clin Invest. 2008 Apr;118(4):1330-43. doi: 10.1172/JCI33873.
3
Drug-induced sexual dysfunction.
Med Toxicol Adverse Drug Exp. 1988 Jul-Aug;3(4):289-306. doi: 10.1007/BF03259941.